At Worldwide, we have extensive experience in managing both common and rare renal disorders, including lupus nephritis, C3 glomerulonephritis, and IgA nephropathy. With over 550 unique nephrology sites across 48 countries, we ensure effective site selection and patient access for your clinical trials. Our services encompass established collaborations with specialized service providers, partnerships with patient advocacy groups, KOL engagement and regulatory meeting support, and more.
To learn more about our expertise and how we can help navigate the complexities of your nephrology study, download our fact sheet.
Worldwide’s Nephrology Experience
Read more